|
Real-time
Euronext Paris
05:40:04 13/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 0.9880 EUR | -1.20% |
|
+9.05% | +65.77% |
| 07/08 | Biosynex hit by cyberattack, operational activity remains intact | |
| 11/06 | Triple update for Biosynex |
Company Valuation: Biosynex
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 151.6 | 289.9 | 141 | 85.85 | 18.51 | 11.17 |
| Change | - | 91.16% | -51.35% | -39.13% | -78.44% | -39.63% |
| Enterprise Value (EV) 1 | 130.6 | 193.2 | 105.9 | 125.7 | 71.44 | 64.36 |
| Change | - | 47.93% | -45.16% | 18.6% | -43.14% | -9.91% |
| P/E | 5.44x | 2.63x | 9.08x | -2.42x | -0.43x | -0.19x |
| PBR | 2.29x | 1.62x | 0.87x | 0.72x | 0.23x | 0.3x |
| PEG | - | 0x | -0.1x | 0x | -0x | 0x |
| Capitalization / Revenue | 0.99x | 0.76x | 0.72x | 0.92x | 0.18x | 0.12x |
| EV / Revenue | 0.85x | 0.5x | 0.54x | 1.35x | 0.71x | 0.68x |
| EV / EBITDA | 2.84x | 1.36x | 2.28x | -4.21x | -3.22x | -4.72x |
| EV / EBIT | 2.86x | 1.37x | 2.72x | -3.48x | -2.59x | -2.47x |
| EV / FCF | 7.61x | 2.62x | -3.59x | -2.83x | -43.6x | 4.54x |
| FCF Yield | 13.1% | 38.1% | -27.9% | -35.3% | -2.29% | 22% |
| Dividend per Share 2 | 0.2 | 2 | - | - | - | - |
| Rate of return | 1.2% | 7.6% | - | - | - | - |
| EPS 2 | 3.05 | 10.01 | 1.52 | -3.45 | -4.03 | -3.159 |
| Distribution rate | 6.56% | 20% | - | - | - | - |
| Net sales 1 | 153.9 | 382.5 | 196.6 | 92.98 | 101.2 | 95.19 |
| EBITDA 1 | 46.02 | 141.8 | 46.49 | -29.82 | -22.16 | -13.64 |
| EBIT 1 | 45.73 | 140.7 | 38.88 | -36.15 | -27.53 | -26.05 |
| Net income 1 | 31.37 | 104 | 15.66 | -36.95 | -43.33 | -58.22 |
| Net Debt 1 | -21.07 | -96.72 | -35.09 | 39.8 | 52.94 | 53.19 |
| Reference price 2 | 16.600 | 26.320 | 13.800 | 8.350 | 1.720 | 0.596 |
| Nbr of stocks (in thousands) | 9,135 | 11,014 | 10,220 | 10,281 | 10,761 | 18,748 |
| Announcement Date | 21/4/21 | 25/4/22 | 28/4/23 | 30/4/24 | 30/4/25 | 7/5/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 21.27M | ||
| -51.41x | 16.79x | -122.41x | -.--% | 22.16B | ||
| 17.89x | 1.99x | 8.4x | 1.43% | 9.92B | ||
| -77.64x | 11.36x | -104.16x | -.--% | 7.52B | ||
| 22.76x | 4.22x | 11.71x | - | 6.57B | ||
| 162.74x | 5.71x | 32.16x | -.--% | 6.29B | ||
| 20.61x | 7.09x | 16.04x | 2.79% | 5.59B | ||
| 21.44x | 3.54x | 10.98x | 1.76% | 4.23B | ||
| 16.28x | - | - | 3.95% | 2.74B | ||
| Average | 16.58x | 7.24x | -21.04x | 1.42% | 7.23B | |
| Weighted average by Cap. | -1.87x | 9.56x | -48.11x | 0.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALBIO Stock
- Valuation Biosynex
Select your edition
All financial news and data tailored to specific country editions
















